Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-20-063479

Options or other derivatives

  • President and CEO acquired 753,804 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Sanjiv President and CEO 2020-12-11 Grant or award · Stock Option (Right to Buy) +753,804 753,804 D
Loading xslF345X03/doc4.xml…